Physician profile
John Ferguson
NPI 1609818871
$7,914.05
in general payments reported to CMS, 2019-2025
19 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,900 · 2020: $25.40 · 2021: $62.28 · 2022: $205 · 2023: $184 · 2024: $358 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $4,706.20 | 2019 | |
| Medical Device Business Services, INC. | $2,100.00 | 2019 | |
| Lundbeck LLC | $215.77 | 2022-2025 | Abilify Maintena |
| Janssen Pharmaceuticals, INC | $198.41 | 2023-2025 | Invega Sustenna, Invega Trinza |
| Otsuka America Pharmaceutical, INC. | $196.42 | 2021-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Alkermes, INC. | $115.79 | 2022-2024 | Aristada, Lybalvi |
| Teva Pharmaceuticals USA, INC. | $88.83 | 2023-2025 | Uzedy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $72.28 | 2022 | |
| Amgen INC. | $30.84 | 2019-2021 | |
| Abbvie INC. | $28.53 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $25.40 | 2020 | |
| Bioxcel Therapeutics, INC. | $22.88 | 2023 | Igalmi |
| Genzyme Corporation | $22.50 | 2021 | |
| Alexion Pharmaceuticals, INC. | $17.12 | 2019 | |
| Celgene Corporation | $16.87 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $16.64 | 2019 | |
| Merck Sharp & Dohme LLC | $15.37 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.36 | 2021 | |
| Portola Pharmaceuticals, LLC | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.